应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03681 中国抗体—B
开市前 05-10 09:06:49
1.830
+0.000
0.00%
最高
1.830
最低
1.830
成交量
0.00
今开
1.830
昨收
1.830
日振幅
0.00%
总市值
19.98亿
流通市值
19.98亿
总股本
10.92亿
成交额
0.00
换手率
0.00%
流通股本
10.92亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中国抗体-B盘中异动 股价大跌5.26%报1.800港元
自选股智能写手 · 04-26
中国抗体-B盘中异动 股价大跌5.26%报1.800港元
中国抗体-B04月15日主力资金流入85万元 连续3日加仓
自选股智能写手 · 04-15
中国抗体-B04月15日主力资金流入85万元 连续3日加仓
中国抗体-B盘中异动 快速上涨6.08%
自选股智能写手 · 04-15
中国抗体-B盘中异动 快速上涨6.08%
中国抗体-B(03681)上涨6.08%,报1.92元/股
金融界 · 04-15
中国抗体-B(03681)上涨6.08%,报1.92元/股
中国抗体-B(03681)股价上升5.525%,现价港币$1.91
阿斯达克财经 · 04-15
中国抗体-B(03681)股价上升5.525%,现价港币$1.91
中国抗体-B04月12日获主力加仓161万元 环比增加544.00%
自选股智能写手 · 04-12
中国抗体-B04月12日获主力加仓161万元 环比增加544.00%
中国抗体-B盘中异动 下午盘快速上涨5.23%报1.810港元
自选股智能写手 · 04-12
中国抗体-B盘中异动 下午盘快速上涨5.23%报1.810港元
中国抗体-B(03681)上涨5.23%,报1.81元/股
金融界 · 04-12
中国抗体-B(03681)上涨5.23%,报1.81元/股
中国抗体-B(03681)股价上升5.096%,现价港币$1.65
阿斯达克财经 · 04-03
中国抗体-B(03681)股价上升5.096%,现价港币$1.65
中国抗体-B盘中异动 临近午盘急速下挫7.07%报1.460港元
自选股智能写手 · 04-03
中国抗体-B盘中异动 临近午盘急速下挫7.07%报1.460港元
核心产品SM03已至规模变现黎明,中国抗体-B(03681)进入价值成长飞跃期
智通财经 · 03-28
核心产品SM03已至规模变现黎明,中国抗体-B(03681)进入价值成长飞跃期
中国抗体-B盘中异动 早盘快速拉升5.44%
自选股智能写手 · 03-26
中国抗体-B盘中异动 早盘快速拉升5.44%
中国抗体-B(03681)发布年度业绩,实现收益136.5万元 各项业务均达到预期表现
智通财经 · 03-25
中国抗体-B(03681)发布年度业绩,实现收益136.5万元 各项业务均达到预期表现
中国抗体-B盘中异动 早盘大幅拉升5.44%
自选股智能写手 · 03-22
中国抗体-B盘中异动 早盘大幅拉升5.44%
中国抗体-B盘中异动 急速上涨5.07%
自选股智能写手 · 03-20
中国抗体-B盘中异动 急速上涨5.07%
中国抗体-B盘中异动 下午盘快速拉升6.69%
自选股智能写手 · 03-18
中国抗体-B盘中异动 下午盘快速拉升6.69%
中国抗体-B(03681)股价上升6.767%,现价港币$1.42
阿斯达克财经 · 03-18
中国抗体-B(03681)股价上升6.767%,现价港币$1.42
中国抗体-B盘中异动 早盘股价大跌6.43%报1.310港元
自选股智能写手 · 03-15
中国抗体-B盘中异动 早盘股价大跌6.43%报1.310港元
中国抗体-B股价上涨13.45% 市值涨2.23亿港元
自选股智能写手 · 03-14
中国抗体-B股价上涨13.45% 市值涨2.23亿港元
中国抗体-B盘中异动 股价大跌5.80%
自选股智能写手 · 03-13
中国抗体-B盘中异动 股价大跌5.80%
暂无数据
公司概况
公司名称:
中国抗体—B
所属市场:
SEHK
上市日期:
--
主营业务:
中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司。该公司主要研制以单克隆抗体为基础的生物制剂和和新化学实体。该公司主要产品SM03是治疗类风湿关节炎的潜在单抗药物。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。
发行价格:
--
{"stockData":{"symbol":"03681","market":"HK","secType":"STK","nameCN":"中国抗体—B","latestPrice":1.83,"timestamp":1715302901382,"preClose":1.83,"halted":0,"volume":0,"delay":0,"floatShares":1091755119,"shares":1091755119,"eps":-0.25825715,"marketStatus":"开市前","marketStatusCode":1,"change":0,"latestTime":"05-10 09:06:49","open":1.83,"high":1.83,"low":1.83,"amount":0,"amplitude":0,"askPrice":1.88,"askSize":29100,"bidPrice":1.79,"bidSize":300,"shortable":0,"etf":0,"ttmEps":-0.2582571627029097,"exchange":"SEHK","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715304600000},"adr":0,"listingDate":1573488000000,"adjPreClose":1.83,"openAndCloseTimeList":[[1715304600000,1715313600000],[1715317200000,1715328000000]],"volumeRatio":0,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03681/tweets","defaultTab":"tweets","newsList":[{"id":"2430293232","title":"中国抗体-B盘中异动 股价大跌5.26%报1.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430293232","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430293232?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:34","pubTimestamp":1714095247,"startTime":"0","endTime":"0","summary":"2024年04月26日早盘09时34分,中国抗体-B股票出现异动,股价快速跳水5.26%。截至发稿,该股报1.800港元/股,成交量300股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出540港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.02%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260934077923a765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260934077923a765&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427237020","title":"中国抗体-B04月15日主力资金流入85万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427237020","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427237020?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:16","pubTimestamp":1713168972,"startTime":"0","endTime":"0","summary":"04月15日, 中国抗体-B股价涨4.97%,报收1.90元,成交金额268万元,换手率0.13%,振幅4.97%,量比3.01。中国抗体-B今日主力资金净流入85万元,连续3日净流入,上一交易日主力净流入161万元,今日环比减少47.20%。该股近5个交易日上涨14.46%,主力资金累计净流入307万元;近20日主力资金累计净流入477万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161635877e8e90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161635877e8e90&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427014875","title":"中国抗体-B盘中异动 快速上涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427014875","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427014875?lang=zh_cn&edition=full","pubTime":"2024-04-15 11:44","pubTimestamp":1713152663,"startTime":"0","endTime":"0","summary":"2024年04月15日临近午盘11时44分,中国抗体-B股票出现异动,股价快速上涨6.08%。中国抗体-B股票所在的生物技术行业中,整体跌幅为1.20%。其相关个股中,乐普生物-B、中国抗体-B、永泰生物-B涨幅较大,振幅较大的相关个股有科济药业-B、乐普生物-B、圣诺医药-B,振幅分别为16.43%、15.14%、11.54%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151144237a52b6c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151144237a52b6c0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427011727","title":"中国抗体-B(03681)上涨6.08%,报1.92元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427011727","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427011727?lang=zh_cn&edition=full","pubTime":"2024-04-15 11:44","pubTimestamp":1713152663,"startTime":"0","endTime":"0","summary":"4月15日,中国抗体-B(03681)盘中上涨6.08%,截至11:44,报1.92元/股,成交232.39万元。中国抗体制药有限公司专注于研究、发展、制造及商业化免疫性疾病疗法,主要研制以单克隆抗体为基础的生物药。公司的旗舰产品SM03已在中国进入类风湿关节炎三期临床试验,并有多个同类靶点首创及同类首创潜在在研药物,覆盖类风湿性关节炎、系统性红斑狼疮、非霍奇金氏淋巴瘤、哮喘等疾病。截至2023年年报,中国抗体-B营业总收入136.5万元、净利润-2.43亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/15114440237567.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427701420","title":"中国抗体-B(03681)股价上升5.525%,现价港币$1.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2427701420","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427701420?lang=zh_cn&edition=full","pubTime":"2024-04-15 11:44","pubTimestamp":1713152640,"startTime":"0","endTime":"0","summary":"[上升股]中国抗体-B(03681) 股价在上午11:44比前收市价上升5.525%,现股价为港币$1.91。至目前为止,今日最高价为$1.91,而最低价为$1.83。总成交量为114.21万股,总成交金额为港币$213.214万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404151243/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426208844","title":"中国抗体-B04月12日获主力加仓161万元 环比增加544.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426208844","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426208844?lang=zh_cn&edition=full","pubTime":"2024-04-12 16:16","pubTimestamp":1712909810,"startTime":"0","endTime":"0","summary":"04月12日, 中国抗体-B股价涨5.23%,报收1.81元,成交金额200万元,换手率0.10%,振幅5.23%,量比4.27。中国抗体-B今日主力资金净流入161万元,上一交易日主力净流入25万元,今日环比增加544.00%。该股近5个交易日上涨10.37%,主力资金累计净流入272万元;近20日主力资金累计净流入392万元,其中净流入天数为8日。该股主力净额占比0.08%,港股市场排名47/2628。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412161810876da0a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412161810876da0a0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426770276","title":"中国抗体-B盘中异动 下午盘快速上涨5.23%报1.810港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426770276","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426770276?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:09","pubTimestamp":1712905747,"startTime":"0","endTime":"0","summary":"2024年04月12日下午盘15时09分,中国抗体-B股票出现异动,股价大幅上涨5.23%。截至发稿,该股报1.810港元/股,成交量112.56万股,换手率0.10%,振幅5.23%。资金方面,该股资金流入186.382万港元,流出12.6525万港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,中生北控生物科技、百奥赛图-B、中国抗体-B涨幅较大,振幅较大的相关个股有百奥赛图-B、圣诺医药-B、博安生物,振幅分别为13.89%、11.89%、11.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412150907861e53c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412150907861e53c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426427915","title":"中国抗体-B(03681)上涨5.23%,报1.81元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426427915","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426427915?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:09","pubTimestamp":1712905747,"startTime":"0","endTime":"0","summary":"4月12日,中国抗体-B(03681)盘中上涨5.23%,截至15:09,报1.81元/股,成交199.03万元。中国抗体制药有限公司专注于研究、发展、制造及商业化免疫性疾病疗法,主要研制以单克隆抗体为基础的生物药。公司的旗舰产品SM03已在中国进入类风湿关节炎三期临床试验,并有多个同类靶点首创及同类首创潜在在研药物,覆盖类风湿性关节炎、系统性红斑狼疮、非霍奇金氏淋巴瘤、哮喘等疾病。截至2023年年报,中国抗体-B营业总收入136.5万元、净利润-2.43亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/12150940214822.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424686962","title":"中国抗体-B(03681)股价上升5.096%,现价港币$1.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2424686962","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2424686962?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:07","pubTimestamp":1712128020,"startTime":"0","endTime":"0","summary":"[上升股]中国抗体-B(03681) 股价在下午03:07比前收市价上升5.096%,现股价为港币$1.65。至目前为止,今日最高价为$1.65,而最低价为$1.46。总成交量为5.73万股,总成交金额为港币$9.023万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404031764/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424858989","title":"中国抗体-B盘中异动 临近午盘急速下挫7.07%报1.460港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424858989","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424858989?lang=zh_cn&edition=full","pubTime":"2024-04-03 11:38","pubTimestamp":1712115480,"startTime":"0","endTime":"0","summary":"2024年04月03日临近午盘11时38分,中国抗体-B股票出现波动,股价大幅下跌7.07%。截至发稿,该股报1.460港元/股,成交量9900股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出1.4454万港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.57%。其相关个股中,华康生物医学、荣昌生物、正大企业国际涨幅较大,振幅较大的相关个股有迈博药业-B、永泰生物-B、圣诺医药-B,振幅分别为9.37%、9.17%、8.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031138007a50dade&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031138007a50dade&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422821601","title":"核心产品SM03已至规模变现黎明,中国抗体-B(03681)进入价值成长飞跃期","url":"https://stock-news.laohu8.com/highlight/detail?id=2422821601","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422821601?lang=zh_cn&edition=full","pubTime":"2024-03-28 13:16","pubTimestamp":1711602983,"startTime":"0","endTime":"0","summary":"年内,中国抗体宣布舒西利单抗在中国治疗RA的III期临床研究达到主要研究终点。截至目前,延伸试验收集的临床数据表明舒西利单抗具有持续性疗效。由此可见,中国抗体对于舒西利单抗的长期疗效及安全性非常有信心。两项检查已于2024年1月完成。目前“警戒素”已被证明与过敏性疾病的病理过程及气道细胞的病毒感染","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094514.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422686080","title":"中国抗体-B盘中异动 早盘快速拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422686080","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422686080?lang=zh_cn&edition=full","pubTime":"2024-03-26 09:48","pubTimestamp":1711417735,"startTime":"0","endTime":"0","summary":"2024年03月26日早盘09时48分,中国抗体-B股票出现波动,股价大幅拉升5.44%。中国抗体-B股票所在的生物技术行业中,整体涨幅为0.10%。年内亏损减少4110万元,由截至2022年12月31日止年度的2.84亿元减少至截至2023年12月31日止年度的2.43亿元,主要原因是SM03的III期临床研究已完成,从而减少研究与开发成本约4500万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032609485587e7ba2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032609485587e7ba2d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422100635","title":"中国抗体-B(03681)发布年度业绩,实现收益136.5万元 各项业务均达到预期表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2422100635","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422100635?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:45","pubTimestamp":1711374342,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国抗体-B 发布截至2023年12月31日止年度业绩,该集团取得收益人民币136.5万元,去年同期收益为零;研究及开发成本1.35亿元,同比减少24.93%;年内亏损2.43亿元,同比收窄14.45%;每股亏损0.24元。2023年,公司的各项业务均达到预期表现,尤其在医药研发方面取得重大突破。公司的旗舰产品SM03是治疗RA的全球首创抗CD22单抗药物,其商业化进程正全速推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1091849.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2421884787","title":"中国抗体-B盘中异动 早盘大幅拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421884787","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421884787?lang=zh_cn&edition=full","pubTime":"2024-03-22 09:58","pubTimestamp":1711072690,"startTime":"0","endTime":"0","summary":"2024年03月22日早盘09时58分,中国抗体-B股票出现异动,股价快速上涨5.44%。中国抗体-B股票所在的生物技术行业中,整体跌幅为1.37%。其相关个股中,华康生物医学、荃信生物-B、来凯医药-B涨幅较大,振幅较大的相关个股有药明巨诺-B、圣诺医药-B、荃信生物-B,振幅分别为11.33%、10.58%、9.43%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032209581087e7adce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032209581087e7adce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420582597","title":"中国抗体-B盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420582597","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420582597?lang=zh_cn&edition=full","pubTime":"2024-03-20 09:58","pubTimestamp":1710899908,"startTime":"0","endTime":"0","summary":"2024年03月20日早盘09时58分,中国抗体-B股票出现异动,股价急速拉升5.07%。截至发稿,该股报1.450港元/股,成交量12.12万股,换手率0.01%,振幅4.35%。中国抗体-B股票所在的生物技术行业中,整体涨幅为0.40%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320095828791b96b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320095828791b96b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420452014","title":"中国抗体-B盘中异动 下午盘快速拉升6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420452014","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420452014?lang=zh_cn&edition=full","pubTime":"2024-03-18 15:02","pubTimestamp":1710745372,"startTime":"0","endTime":"0","summary":"2024年03月18日下午盘15时02分,中国抗体-B股票出现波动,股价大幅上涨6.69%。截至发稿,该股报1.420港元/股,成交量6000股,换手率0.00%,振幅4.51%。中国抗体-B股票所在的生物技术行业中,整体涨幅为0.11%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031815025287e79b4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031815025287e79b4a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420641040","title":"中国抗体-B(03681)股价上升6.767%,现价港币$1.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2420641040","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420641040?lang=zh_cn&edition=full","pubTime":"2024-03-18 15:02","pubTimestamp":1710745320,"startTime":"0","endTime":"0","summary":"[上升股]中国抗体-B(03681) 股价在下午03:02比前收市价上升6.767%,现股价为港币$1.42。至目前为止,今日最高价为$1.42,而最低价为$1.36。总成交量为3900股,总成交金额为港币$5538。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403181754/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2419967838","title":"中国抗体-B盘中异动 早盘股价大跌6.43%报1.310港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419967838","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419967838?lang=zh_cn&edition=full","pubTime":"2024-03-15 09:48","pubTimestamp":1710467287,"startTime":"0","endTime":"0","summary":"2024年03月15日早盘09时48分,中国抗体-B股票出现异动,股价大幅下挫6.43%。截至发稿,该股报1.310港元/股,成交量300股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出393港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.50%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031509480787e791b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031509480787e791b2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419468186","title":"中国抗体-B股价上涨13.45% 市值涨2.23亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419468186","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419468186?lang=zh_cn&edition=full","pubTime":"2024-03-14 13:43","pubTimestamp":1710395030,"startTime":"0","endTime":"0","summary":"2024年03月14日下午盘13时43分,中国抗体-B股票出现波动,股价大幅拉升13.45%。截至发稿,该股报1.510港元/股,成交量18万股,换手率0.02%,振幅15.04%。资金方面,该股资金流入10.8549万港元,流出12.7806万港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,泰格医药、科伦博泰生物-B、昭衍新药涨幅较大,振幅较大的相关个股有科伦博泰生物-B、药明合联、药明康德,振幅分别为23.67%、21.76%、19.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403141343507a4c8f7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403141343507a4c8f7f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419735521","title":"中国抗体-B盘中异动 股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419735521","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419735521?lang=zh_cn&edition=full","pubTime":"2024-03-13 13:37","pubTimestamp":1710308242,"startTime":"0","endTime":"0","summary":"2024年03月13日下午盘13时37分,中国抗体-B股票出现异动,股价急速跳水5.80%。截至发稿,该股报1.300港元/股,成交量15.96万股,换手率0.01%,振幅5.80%。资金方面,该股资金流入1.7802万港元,流出9.0147万港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.13%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313133723861ddc77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313133723861ddc77&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinomab.com","stockEarnings":[{"period":"1week","weight":-0.0368},{"period":"1month","weight":0.0702},{"period":"3month","weight":0.3071},{"period":"6month","weight":0.6789},{"period":"1year","weight":0.011},{"period":"ytd","weight":0.0893}],"compareEarnings":[{"period":"1week","weight":0.0182},{"period":"1month","weight":0.1016},{"period":"3month","weight":0.1773},{"period":"6month","weight":0.0776},{"period":"1year","weight":-0.062},{"period":"ytd","weight":0.0874}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司。该公司主要研制以单克隆抗体为基础的生物制剂和和新化学实体。该公司主要产品SM03是治疗类风湿关节炎的潜在单抗药物。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.013788},{"month":2,"riseRate":0.2,"avgChangeRate":-0.060562},{"month":3,"riseRate":0.2,"avgChangeRate":-0.049178},{"month":4,"riseRate":0.8,"avgChangeRate":0.04218},{"month":5,"riseRate":0.2,"avgChangeRate":0.010245},{"month":6,"riseRate":0.25,"avgChangeRate":-0.004085},{"month":7,"riseRate":0.25,"avgChangeRate":-0.082411},{"month":8,"riseRate":0.25,"avgChangeRate":-0.088732},{"month":9,"riseRate":0.25,"avgChangeRate":-0.027102},{"month":10,"riseRate":0,"avgChangeRate":-0.065139},{"month":11,"riseRate":1,"avgChangeRate":0.047709},{"month":12,"riseRate":0.4,"avgChangeRate":0.133947}],"exchange":"SEHK","name":"中国抗体—B","nameEN":"SINOMAB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国抗体—B(03681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国抗体—B(03681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国抗体—B,03681,中国抗体—B股票,中国抗体—B股票老虎,中国抗体—B股票老虎国际,中国抗体—B行情,中国抗体—B股票行情,中国抗体—B股价,中国抗体—B股市,中国抗体—B股票价格,中国抗体—B股票交易,中国抗体—B股票购买,中国抗体—B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国抗体—B(03681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国抗体—B(03681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}